Effect of Hoechunyangkyeok-San Extract on Melanogenesis
Citations Over Time
Abstract
Forsythia fructus has been shown to have antioxidative, anti-inflammatory, antibacterial, anti-aging and whitening effects. Hoechunyangkyeok-san (Forsythia viridissima-prescription) is a traditional herbal medicine, which has been clinically used for treating febrile and inflammatory disorders. This work was carried out to investigate the skin whitening effects of Forsythia viridissima-prescription extract (a hydrolyzed extract of Hoechunyangkyeok-san: SID White HYC) on skin. The effects of SID White HYC were assessed the melanin contents in B161 melanoma cells and the pigmented equivalent with HMB45 and Fontana Masson staining in 3D skin model. Then, we examined the expression of major pigment enzymes regulating melanin synthesis and melanosome transport related proteins in B16F1 cells. SID White HYC significantly inhibited the melanin synthesis (56.7% and 30.6% inhibition at 100 μg/mL, intracellular and secreted, respectively) in B16F1 cells and 3D skin model. In addition, western blotting analysis showed that SID White HYC reduced the expression of melanin synthesis and melanosome transport related proteins in B16F1 cells. In clinical trials, the cream containing 0.05% SID White HYC showed skin depigmentation effect without any irritation. These results suggest that SID White HYC may be useful inhibition of melanogenesis and melanosome transport. Therefore, SID White HYC may have potential as a skin-whitening ingredient in cosmetics.
Related Papers
- → Mimicking Melanosomes: Polydopamine Nanoparticles as Artificial Microparasols(2017)161 cited
- Characterization of melanogenesis and morphogenesis of melanosomes by physicochemical properties of melanin and melanosomes in malignant melanoma.(1984)
- → Dynamic visualization of melanosome endo/phagocytosis during melanin transfer using melanosomes pre-stained with carbocyanine dyes(2021)4 cited
- → The Site of Biosynthesis of Mammalian Tyrosinase11From the Research Laboratories of the Department of Dermatology of the Harvard Medical School at the Massachusetts General Hospital, Boston 14, Massachusetts and The Chester Beatty Research Institute, Institute of Cancer Research, Royal Cancer Hospital, London, S.W.3, England.This work was supported by Grant #CY-5010 of the National Institutes of Health, U.S. Public Health Service, Department of Health, Education and Welfare and by Grant 257-E of the Damon Runyon Memorial Fund for Cancer Research, Inc.Presented at the Twenty-second Annual Meeting of The Society for Investigative Dermatology, Inc., New York, N.Y., June 27, 1961.(1961)14 cited
- → Amelanotic malignant melanoma: recognizing aberrant premelanosomes(1995)